Maximus, Inc. (NYSE:MMS) Shares Acquired by Farther Finance Advisors LLC

Farther Finance Advisors LLC boosted its holdings in Maximus, Inc. (NYSE:MMS) by 109.2% in the 4th quarter, Holdings Channel reports. The firm owned 820 shares of the health services provider’s stock after purchasing an additional 428 shares during the period. Farther Finance Advisors LLC’s holdings in Maximus were worth $61,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently bought and sold shares of the company. Reinhart Partners LLC. grew its holdings in shares of Maximus by 43.5% during the fourth quarter. Reinhart Partners LLC. now owns 551,146 shares of the health services provider’s stock worth $41,143,000 after buying an additional 167,019 shares during the last quarter. Sio Capital Management LLC purchased a new position in shares of Maximus in the 3rd quarter valued at approximately $14,453,000. Ruffer LLP purchased a new position in shares of Maximus in the 4th quarter valued at approximately $10,266,000. Barclays PLC increased its holdings in shares of Maximus by 285.1% in the third quarter. Barclays PLC now owns 170,971 shares of the health services provider’s stock valued at $15,927,000 after purchasing an additional 126,573 shares during the period. Finally, Empowered Funds LLC purchased a new stake in shares of Maximus during the fourth quarter worth approximately $8,139,000. Institutional investors and hedge funds own 97.21% of the company’s stock.

Analyst Upgrades and Downgrades

MMS has been the topic of a number of analyst reports. Raymond James raised Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price objective on the stock in a report on Thursday, January 2nd. StockNews.com cut Maximus from a “buy” rating to a “hold” rating in a report on Friday, February 14th.

Maximus Stock Down 0.1 %

Maximus stock opened at $67.12 on Friday. Maximus, Inc. has a fifty-two week low of $63.77 and a fifty-two week high of $93.97. The firm has a market capitalization of $3.80 billion, a price-to-earnings ratio of 14.43 and a beta of 0.71. The stock’s fifty day moving average is $71.07 and its two-hundred day moving average is $78.55. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72.

Maximus (NYSE:MMS) last released its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. Analysts predict that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Saturday, February 15th were given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 1.79%. The ex-dividend date of this dividend was Friday, February 14th. Maximus’s dividend payout ratio (DPR) is 25.81%.

Insiders Place Their Bets

In other Maximus news, insider Ilene R. Baylinson sold 14,500 shares of the business’s stock in a transaction dated Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the transaction, the insider now owns 2,512 shares in the company, valued at $171,167.68. The trade was a 85.23 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Jan Madsen sold 2,439 shares of the stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total transaction of $165,144.69. Following the completion of the sale, the director now directly owns 18,097 shares of the company’s stock, valued at $1,225,347.87. This trade represents a 11.88 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by insiders.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.